
Craig D. Ricci
Examiner (ID: 10445, Phone: (571)270-5864 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1611, 1628, 1614 |
| Total Applications | 1547 |
| Issued Applications | 760 |
| Pending Applications | 153 |
| Abandoned Applications | 681 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18739454
[patent_doc_number] => 20230348376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => VITAMIN D DERIVATIVE HAVING CYCLIC AMINE IN SIDE CHAIN
[patent_app_type] => utility
[patent_app_number] => 18/025762
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025762
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025762 | VITAMIN D DERIVATIVE HAVING CYCLIC AMINE IN SIDE CHAIN | Sep 13, 2021 | Pending |
Array
(
[id] => 18466986
[patent_doc_number] => 20230201266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => METHOD FOR TREATING ARTHRITIS BY USING STEM CELL PREPARATION AND METHOD FOR PREPARING STEM CELL PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/470487
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470487
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470487 | Method for treating arthritis by using stem cell preparation and method for preparing stem cell preparation | Sep 8, 2021 | Issued |
Array
(
[id] => 17560909
[patent_doc_number] => 20220125058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => APPLICATION OF ATRACTYLODES LANCEOLATA ESSENTIAL OIL
[patent_app_type] => utility
[patent_app_number] => 17/447090
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17447090
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/447090 | APPLICATION OF ATRACTYLODES LANCEOLATA ESSENTIAL OIL | Sep 7, 2021 | Abandoned |
Array
(
[id] => 17314388
[patent_doc_number] => 20210403436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/467772
[patent_app_country] => US
[patent_app_date] => 2021-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17467772
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/467772 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING DISEASES | Sep 6, 2021 | Abandoned |
Array
(
[id] => 18647730
[patent_doc_number] => 20230293500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => AK3287 PREPARATION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/024343
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024343
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024343 | AK3287 PREPARATION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Sep 1, 2021 | Pending |
Array
(
[id] => 20114995
[patent_doc_number] => 12364679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Esters for treatment of ocular inflammatory conditions
[patent_app_type] => utility
[patent_app_number] => 17/445520
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7105
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/445520 | Esters for treatment of ocular inflammatory conditions | Aug 19, 2021 | Issued |
Array
(
[id] => 17655439
[patent_doc_number] => 20220175904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHODS AND COMPOSITIONS RELATING TO SYNTHETIC BETA-1,6 GLUCOSAMINE OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/408287
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17408287
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/408287 | METHODS AND COMPOSITIONS RELATING TO SYNTHETIC BETA-1,6 GLUCOSAMINE OLIGOSACCHARIDES | Aug 19, 2021 | Abandoned |
Array
(
[id] => 20114995
[patent_doc_number] => 12364679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Esters for treatment of ocular inflammatory conditions
[patent_app_type] => utility
[patent_app_number] => 17/445520
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7105
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/445520 | Esters for treatment of ocular inflammatory conditions | Aug 19, 2021 | Issued |
Array
(
[id] => 20114995
[patent_doc_number] => 12364679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Esters for treatment of ocular inflammatory conditions
[patent_app_type] => utility
[patent_app_number] => 17/445520
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7105
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/445520 | Esters for treatment of ocular inflammatory conditions | Aug 19, 2021 | Issued |
Array
(
[id] => 20114995
[patent_doc_number] => 12364679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Esters for treatment of ocular inflammatory conditions
[patent_app_type] => utility
[patent_app_number] => 17/445520
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7105
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/445520 | Esters for treatment of ocular inflammatory conditions | Aug 19, 2021 | Issued |
Array
(
[id] => 17426871
[patent_doc_number] => 20220054579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF LYSOSOMAL STORAGE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/404680
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17404680
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/404680 | Methods and compositions for treatment of lysosomal storage disorders | Aug 16, 2021 | Issued |
Array
(
[id] => 17412056
[patent_doc_number] => 20220046960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => BEVERAGE COMPOSITION AND PROCESS
[patent_app_type] => utility
[patent_app_number] => 17/398827
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17398827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/398827 | BEVERAGE COMPOSITION AND PROCESS | Aug 9, 2021 | Pending |
Array
(
[id] => 17368208
[patent_doc_number] => 20220023260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Ready to Use Ketorolac Formulations
[patent_app_type] => utility
[patent_app_number] => 17/396890
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7250
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396890
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/396890 | Ready to Use Ketorolac Formulations | Aug 8, 2021 | Pending |
Array
(
[id] => 18597131
[patent_doc_number] => 20230271923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => IMAGING AND TARGETING PROGRAMMED DEATH LIGAND-1 (PD-LI) EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/040858
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040858
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040858 | IMAGING AND TARGETING PROGRAMMED DEATH LIGAND-1 (PD-LI) EXPRESSION | Aug 5, 2021 | Pending |
Array
(
[id] => 18075892
[patent_doc_number] => 20220401504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => USE OF MAGNOLIA FIGO EXTRACT IN THE MANUFACTURE OF COMPOUND FOR INHIBITING GROWTH OF LUNG CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 17/394047
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17394047
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/394047 | Use of Magnolia figo extract in the manufacture of compound for inhibiting growth of lung cancer cells | Aug 3, 2021 | Issued |
Array
(
[id] => 18674972
[patent_doc_number] => 20230312495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => NEW ISOBUTYRAMIDE DERIVATIVES, COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID COMPOUNDS, AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF SENSITIVE, IN PARTICULAR INFLAMED SKIN OR INFLAMMATORY SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/041742
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041742
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041742 | NEW ISOBUTYRAMIDE DERIVATIVES, COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID COMPOUNDS, AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF SENSITIVE, IN PARTICULAR INFLAMED SKIN OR INFLAMMATORY SKIN CONDITIONS | Aug 1, 2021 | Pending |
Array
(
[id] => 18581522
[patent_doc_number] => 20230263774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => OPTIMIZED SURGERY PROTOCOL AND KITS
[patent_app_type] => utility
[patent_app_number] => 18/040959
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22441
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040959
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040959 | OPTIMIZED SURGERY PROTOCOL AND KITS | Jul 29, 2021 | Pending |
Array
(
[id] => 18657619
[patent_doc_number] => 20230303543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => NOVEL STIRIPENTOL DERIVATIVE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/018792
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018792
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018792 | Stiripentol derivative and use thereof | Jul 29, 2021 | Issued |
Array
(
[id] => 18656032
[patent_doc_number] => 20230301898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => EMULSIFIER COMPOSITION FOR PERSONAL CARE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/018663
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018663
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018663 | EMULSIFIER COMPOSITION FOR PERSONAL CARE FORMULATION | Jul 29, 2021 | Pending |
Array
(
[id] => 18902638
[patent_doc_number] => 20240018123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => COMPOUND FOR INHIBITING OR DISINTEGRATING ANDROGEN RECEPTOR, AND PHARMACEUTICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/017997
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017997
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017997 | COMPOUND FOR INHIBITING OR DISINTEGRATING ANDROGEN RECEPTOR, AND PHARMACEUTICAL USE THEREOF | Jul 27, 2021 | Pending |